SEC Filing Details

Document Details

Form
Filing Date
Jul 31, 2024
Document Date
Jul 29, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Fate Therapeutics, Inc.
Issuer
FATE THERAPEUTICS INC
Filer
MOZAFFARIAN NEELUFAR